Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
Recent News View All News
Email Alerts
Sign up for email alerts for Press Releases & SEC Filings